MBX Biosciences Company
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Industry:
PharmTech
Technology:
Others
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Investors Number:
6
Headquarters:
Carmel, Indiana, United States
Employee Number:
1-10
Investor Type:
For Profit
Total Funding:
$59.9M
Founded Date:
2019
Last Funding Type:
Series A